Kimberly L. Rockley

Alderley Park
Macclesfield, ENG SK104TG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Building structure activity relationships (SAR) to avoid toxicity due to unwanted CNS ion channel activity.

Building structure activity relationships (SAR) to avoid toxicity due to unwanted CNS ion channel activity.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: July 30, 2026

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

Journal: Pharmacology research & perspectives

Published: May 04, 2026

25 years of applying the 3Rs principles in safety pharmacology: success stories and future perspectives.

25 years of applying the 3Rs principles in safety pharmacology: success stories and future perspectives.

Journal: Frontiers in physiology

Published: February 19, 2026

Use of new approach methodologies (NAMs) in epilepsy research and seizure risk assessment.

Use of new approach methodologies (NAMs) in epilepsy research and seizure risk assessment.

Journal: Drug discovery today

Published: September 02, 2025

An integrated approach for early in vitro seizure prediction utilizing hiPSC neurons and human ion channel assays.

An integrated approach for early in vitro seizure prediction utilizing hiPSC neurons and human ion channel assays.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: August 26, 2023

Innovative models for in vitro detection of seizure.

Innovative models for in vitro detection of seizure.

Journal: Toxicology research

Published: August 08, 2019

Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics.

Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics.

Journal: Pharmacology & therapeutics

Published: October 18, 2018

Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors.

Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors.

Journal: ChemPlusChem

Published: August 11, 2016

Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity.

Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: July 29, 2016

Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors.

Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors.

Journal: British journal of pharmacology

Published: April 25, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026